OC
Orthocell Limited
OCC.AX · ASX
$0.73 +0.00% (+$0.00)
1M -2.70%
Market Cap $197.4M
P/E Ratio -
Div. Yield -
ROE 50.70%
Piotroski F-Score Weak
2/9Valuation
14 /100
Expensive P/B 5.74x
P/S 17.31x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 77.54%
Rev. growth 39.05%
FCF growth N/A
Profitability
12 /100
Weak Op. margin 161.15%
Gross margin 32.24%
FCF margin 126.47%
Quality
3 /100
Poor ROA 25.39%
ROIC 38.75%
Asset turnover 0.21x
Debt
100 /100
Low Current ratio 5.97x
Debt/Equity 0.05x
Debt/Assets N/A
Stability
66 /100
Moderate EPS volatility 15.95%
Beta -0.07x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OCC.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Frederick Anderson
Employees
37
Headquarters
Murdoch
Prihajajoči dogodki
19 FEB.
Earnings
Upcoming earnings report